Fed Regist. 1997 Aug 6;62(151):42219-20.
The U.S. Nuclear Regulatory Commission (NRC) has developed a program for revising the regulations governing the medical use of byproduct material. The decision to revise this regulation resulted from the NRC Strategic Assessment and Rebaselining Initiative (SA), a process involving identification of the direction-setting issues and associated options for the future of NRC activities. This notice describes the NRC's program for revising the medical use regulation; notifies the public of the availability of documents associated with this action on the NRC Technical Conference Forum and through the NRC Public Document Room; and solicits informal public input on development of proposed rule language and associated documents. The Commission plans to formally propose specific rulemaking text for public comment during summer of 1998.
美国核管理委员会(NRC)已制定了一项计划,用于修订有关副产品材料医疗用途的规定。修订该规定的决定源于NRC战略评估与重新基线计划(SA),这一过程涉及确定NRC活动未来的方向性问题及相关选项。本通知描述了NRC修订医疗用途规定的计划;通知公众可在NRC技术会议论坛以及通过NRC公共文件室获取与该行动相关的文件;并就拟议规则语言及相关文件的制定征求公众的非正式意见。委员会计划在1998年夏季正式提出具体的法规制定文本以供公众评论。